https://orcid.org/0000-0002-8463-1947
Overview
As a physician-investigator my research focus is to identify new therapies and strategies to improve outcomes in persons living with Chronic Obstructive Pulmonary Disease (COPD). In pursuit of this goal, I've focused my research in the following areas: 1) clinical trial investigation of novel COPD therapeutics, 2) investigating mechanisms responsible for the treatment response to pulmonary rehabilitation through an aging lens, and 3) risk of cardiovascular disease in COPD.
Current Duke Appointments & Affiliations
Assistant Professor of Medicine
·
2023 - Present
Medicine, Pulmonary, Allergy, and Critical Care Medicine,
Medicine
Member in the Duke Clinical Research Institute
·
2021 - Present
Duke Clinical Research Institute,
Institutes and Centers
Recent News Items
View All News Items
Recent Scholarly Works
Respiratory mortality per STAR, GOLD, and ERS/ATS COPD severity classification.
Journal article Annals of the American Thoracic Society · July 2026 Full text CitePulmonary rehabilitation prolongs life…and may be dying.
Journal article Am J Respir Crit Care Med · June 1, 2026 Full text Link to item CiteAspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Chronic Obstructive Pulmonary Disease and Asthma: Insights From ADAPTABLE.
Journal article J Am Heart Assoc · December 2, 2025 BACKGROUND: Guidelines recommend aspirin (75-100 mg daily) for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD). However, it is unknown if people with a history of ASCVD and chronic obstructive pulmonary disease (COPD) or asthma, ... Full text Link to item CiteRecent Grants
Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations (INSPIRE-COPD-E).
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2025 - 2030Blueprint-COPD: Coping skills support for patients with comorbid COPD and anxiety or depression
ResearchInvestigator · Awarded by American Lung Association · 2025 - 2028RofLumilast or Azithromycin to preveNt COPD Exacerbations (RELIANCE) - REIMBURSEABLE
ResearchPrincipal Investigator · Awarded by University of Illinois at Chicago · 2017 - 2027View All Grants
Education
Duke University ·
2021
M.H.S.
Indiana University, School of Medicine ·
2014
M.D.